TREATMENT:

 Modified Radical
Mastectomy and Breast
Reconstruction: Cancer
will be surgical removed
firstly and then prosthesis
implantation and
autologous tissue
transplantation will be
performed to reconstruct
a breast according to
patients’ condition

MANAGEMENT:

 Provide support when

patient is informed of
diagnosis and treatment
plan.
 Explain rationale for
treatments and anticipated
side effects, and their
management.
 Encourage patient and s.o
to discuss their quality of
life concerns openly with
the health care team.
 Assess coping and support
needs of patient and family.
TREATMENT:
PREVENTION AND SCREENING PREVENTION Management:
 Surgical Resection: Big
Trauma, high risk, easy to  Prophylactic  Prompt recognition
opherectomy will reduce  Radical
have complications, not of precursor lesions
suitable for advanced breast but do not eliminate the such as endometrial prostatectomy
cancer patient. For some of risk for development of hyperplasia can  Radiation
the breast cancer patients, ovarian cancer prevent disease therapy
mastectomy will affect their  Pelvic examinations progression  Expectant
quality of life.  Measuring the levels of  Oral contraceptive management or
 Radiation and tumor markers (CA 125) use – has a rotective watchful waiting
Chemotherapy: Chemotherap  Pelvic ultrasonography in effect against the
y kills normal cells while high risk women development of
killing cancer cells, resulting in  Transvaginal ultrasound endometrial cancer
damage to the immune  Proteomics  Controlling for Diagnosis
system, and have toxic side
obesity, diabetes and
effects such as: hair loss,  Elevated PSA or
hypertension
vomiting, etc. It is not suitable
for advanced breast cancer  Adding progesterone abnormal DRE
patients. to estrogen  Biopsy
DETECTION : replacement  Computed
 Cryotherapy: compared with 
 Women with early-stage Avoiding tamoxifen tomography
surgery, cryotherapy is use and a high-fat
associated with lower risks
ovarian cancer are often  Magnetic
asymptomatic, making diet are also
and less complications. little resonance
early detection difficult recommended
bleeding and quick recovery; imaging
 Pap smear
few damage to normal tissues  Radionucleotide
and can be performed  Palpation of the pelvic
scanning
repeatedly to prevent mass chest x-rays and CT SCREENING AND DETECTION
recurrence of breast cancer. scans are used to
 Particle evaluate metastatic  Detected by Pap smear
Implantation: Implanted disease occasionally
particles will keep emitting y-  Physical exam –
ray within the tumor, important to inspect and
targeting to the cancer cells palpate the vulve, the
accurately; the radiation of vagina,and the cervix to
seeds to tumor last for 180 exclude metastatic
days, high accuracy, disease
millimeter minimally  Rectovaginal exam- to
invasive; few toxic side assess the fallopian
effects and complications tubes and ovaries
 Modified Radical
 HORMONAL ONCOGENESIS

BREAST CANCER OVARIAN CANCER ENDOMETRIAL CANCER PROSTATE CANCER

Hormone Responsible: Hormone Responsible: Hormone Responsible: Hormone Responsible:
Estrogen and
Estrogen Estrogen and Testosterone
Progesterone
Progesterone

Risk Factors: Risk Factors: Risk Factors:

 Use of Oral Risk Factors  Age (55 & up )

 Prior reproductive
Contraceptives or history  Heredity  Family History
Hormone  Number of Ovulatory  Estrogen Exposure (  Increased Fat
Replacement cycles (with low , estrogen intake
Therapy early menarche and late replacement therapy  Red meat
 Obesity and menopause) and obesity) consumption
Dietary Fat  Environmental Factors  Late menopause  Increased dietary
 Radiation  Nulliparity  Irregular Menstrual animal fat
Exposure  History of pelvic History
 Alcohol inflammatory disease  Living in
 Failure to ovulate
Consumption  Family history of breast increased
 History of Infertility
or ovarian cancer  Tamoxifen use latitudes with
less sun
exposure and
Vit. D
 Vit. Ddeficient